Trial intelligence / Profile preview

Lithium for Prevention of Alzheimer's Disease in MCI Patients

NCT01055392Phase 2Unknown

Sponsor
Universidade de São Paulo
Start
Mar 2007
Primary completion
Mar 2009
Countries
1
01

Overview

A Phase 2 trial of lithium carbonate in Alzheimer's disease (AD), Mild Cognitive Impairment (MCI), sponsored by Universidade de São Paulo. Status: unknown.

02

Drugs

lithium carbonate
03

Conditions

Alzheimer's disease (AD)Mild Cognitive Impairment (MCI)

Beyond the preview

Go deeper on NCT01055392.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01055392.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call